MYC and TRIM24, both predicted to be activated by optoVNS, are important cardiac transcription factors involved in cardiac development and both play important roles in modulation of cardiac hypertrophy (70, 71). The gene discussed is TRIM24; the disease is cardiac hypertrophy.